 Relation humoral responses HIV gag env proteins seroconversion clinical outcome HIV infection OBJECTIVE contribution humoral response HIV-I seroconversion outcome months DESIGN retrospective longitudinal study SETTING haemophilia centres United Kingdom PATIENTS Haemophiliac patients HIV-I sera available seroconversion clinical data available RESULTS Kaplan-Meier survival analysis significant difference high titre antibody response seroconversion prolonged time development HIV related disease contrast titres antibody seroconversion rapid clinical deterioration CONCLUSIONS first humoral response HIV proteins seroconversion clinical outcome patients initial low titre antibody response protein rate progression CDC stage IV disease Patients high titre antibody response progress AIDS data explanation antigenaemia patients AIDS unclear association strong initial antibody response progression HIV disease causal due viral host factors